TY - JOUR
T1 - COMPAR-EU Recommendations on Self-Management Interventions in Type 2 Diabetes Mellitus
AU - Beltran, Jessica
AU - Valli, Claudia
AU - Medina-Aedo, Melixa
AU - Canelo-Aybar, Carlos
AU - Nino de Guzman, Eno
AU - Song, Yang
AU - Orrego, Carola
AU - Ballester, Marta
AU - Sunol, Rosa
AU - Noordman, Janneke
AU - Heijmans, Monique
AU - Seitidis, Georgios
AU - Tsokani, Sofia
AU - Mavridis, Dimitris
AU - Kontouli, Katerina-Maria
AU - Christogiannis, Christos
AU - Mavridis, Dimitris
AU - de Graaf, Gimon
AU - Groene, Oliver
AU - Grammatikopoulou, Maria G.
AU - Camalleres-Guillem, Francisco
AU - Perestelo-Perez, Lilisbeth
AU - McGloin, Helen
AU - Winkley, Kirsty
AU - Sigrid Mueller, Beate
AU - Saz-Parkinson, Zuleika
AU - Corcoy, Rosa
AU - Alonso-Coello, Pablo
N1 - Funding Information:
Funding: This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 754936. The funders had no role in the process of formulation of the recommendations.
Publisher Copyright:
© 2024 by the authors.
PY - 2024/2/16
Y1 - 2024/2/16
N2 - Self-management interventions (SMIs) offer a promising approach to actively engage patients in the management of their chronic diseases. Within the scope of the COMPAR-EU project, our goal is to provide evidence-based recommendations for the utilisation and implementation of SMIs in the care of adult individuals with type 2 diabetes mellitus (T2DM). A multidisciplinary panel of experts, utilising a core outcome set (COS), identified critical outcomes and established effect thresholds for each outcome. The panel formulated recommendations using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach, a transparent and rigorous framework for developing and presenting the best available evidence for the formulation of recommendations. All recommendations are based on systematic reviews (SR) of the effects and of values and preferences, a contextual analysis, and a cost-effectiveness analysis. The COMPAR-EU panel is in favour of using SMIs rather than usual care (UC) alone (conditional, very low certainty of the evidence). Furthermore, the panel specifically is in favour of using ten selected SMIs, rather than UC alone (conditional, low certainty of the evidence), mostly encompassing education, self-monitoring, and behavioural techniques. The panel acknowledges that, for most SMIs, moderate resource requirements exist, and cost-effectiveness analyses do not distinctly favour either the SMI or UC. Additionally, it recognises that SMIs are likely to enhance equity, deeming them acceptable and feasible for implementation.
AB - Self-management interventions (SMIs) offer a promising approach to actively engage patients in the management of their chronic diseases. Within the scope of the COMPAR-EU project, our goal is to provide evidence-based recommendations for the utilisation and implementation of SMIs in the care of adult individuals with type 2 diabetes mellitus (T2DM). A multidisciplinary panel of experts, utilising a core outcome set (COS), identified critical outcomes and established effect thresholds for each outcome. The panel formulated recommendations using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach, a transparent and rigorous framework for developing and presenting the best available evidence for the formulation of recommendations. All recommendations are based on systematic reviews (SR) of the effects and of values and preferences, a contextual analysis, and a cost-effectiveness analysis. The COMPAR-EU panel is in favour of using SMIs rather than usual care (UC) alone (conditional, very low certainty of the evidence). Furthermore, the panel specifically is in favour of using ten selected SMIs, rather than UC alone (conditional, low certainty of the evidence), mostly encompassing education, self-monitoring, and behavioural techniques. The panel acknowledges that, for most SMIs, moderate resource requirements exist, and cost-effectiveness analyses do not distinctly favour either the SMI or UC. Additionally, it recognises that SMIs are likely to enhance equity, deeming them acceptable and feasible for implementation.
UR - http://www.scopus.com/inward/record.url?scp=85185693612&partnerID=8YFLogxK
U2 - 10.3390/healthcare12040483
DO - 10.3390/healthcare12040483
M3 - Article
SN - 2227-9032
VL - 12
JO - Healthcare
JF - Healthcare
IS - 4
M1 - 483
ER -